Hamza Mameri
YOU?
Author Swipe
View article: The Role of Barley, Sorghum, Rice, and Maize in North African Cuisine
The Role of Barley, Sorghum, Rice, and Maize in North African Cuisine Open
Background: Cereal-based foods have been a cornerstone of North African diets for centuries, with grains such as barley, rice, maize, and sorghum holding significant importance for food security, nutritional well-being, and cultural identi…
View article: Polysaccharide distribution and cell wall deposition in the endosperm and outer layers of developing sorghum grains
Polysaccharide distribution and cell wall deposition in the endosperm and outer layers of developing sorghum grains Open
International audience
View article: Modifications in lipids and storage proteins composition during germination of chia seeds (Salvia hispanica L.)
Modifications in lipids and storage proteins composition during germination of chia seeds (Salvia hispanica L.) Open
Salvia hispanica L. (chia) is a plant of the Lamiaceae family native to Central America, is mainly grown in southwestern France, with a preference for the ORURO® variety. Chia seeds contain over 30 % oil and 19 % protein. They are rich in …
View article: Dynamic Metabolomic Changes in the Phenolic Compound Profile and Antioxidant Activity in Developmental Sorghum Grains
Dynamic Metabolomic Changes in the Phenolic Compound Profile and Antioxidant Activity in Developmental Sorghum Grains Open
Phenolic compounds (PC) were analyzed by UHPLC-ESI-QTOF-MSE in two sorghum genotypes, harvested in two growing seasons (GS) at five distinct days after flowering (DAF) to evaluate how genotype/GS influences the PC synthesis and antioxidant…
View article: Enhancing the nutritional value of sorghum grains bred for northern Europe through processing: A perspective on phenolic bioaccessibility and protein digestibility
Enhancing the nutritional value of sorghum grains bred for northern Europe through processing: A perspective on phenolic bioaccessibility and protein digestibility Open
The effect of dehulling and cooking on the in vitro digestibility, and phenolic profiles was evaluated for four Dutch sorghum varieties (HD7 and HD19, Sorghum bicolor; and HD100 and HD101 Sorghum nigricans) bred in the Netherlands. Protein…
View article: THE EXTRUSION ROLE IN PHENOLIC COMPOUND AND PROTEIN BIOACCESSIBILITY FOR SORGHUM BASED PRODUCTS: A INFOGEST PROTOCOL-BASED STUDY
THE EXTRUSION ROLE IN PHENOLIC COMPOUND AND PROTEIN BIOACCESSIBILITY FOR SORGHUM BASED PRODUCTS: A INFOGEST PROTOCOL-BASED STUDY Open
International audience
View article: Site-directed mutagenesis and structural investigation of the antigenicity of wheat allergen LTP1 (Tri a 14)
Site-directed mutagenesis and structural investigation of the antigenicity of wheat allergen LTP1 (Tri a 14) Open
International audience
View article: Supplementary Figure S3 from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer
Supplementary Figure S3 from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer Open
Depletion of CDA expression by short hairpin RNA in HeLa cells.
View article: Supplementary Table S1 from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer
Supplementary Table S1 from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer Open
Comparison of CDA mRNA expression data between cancerous and non-cancerous tissues.
View article: Supplementary Table S3 from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer
Supplementary Table S3 from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer Open
Pearson correlation between the levels of CDA transcripts and the cytotoxicity of a panel of drugs.
View article: Supplementary Figure S3 from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer
Supplementary Figure S3 from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer Open
Depletion of CDA expression by short hairpin RNA in HeLa cells.
View article: Supplementary Figure S1 from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer
Supplementary Figure S1 from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer Open
CDA expression levels in cancer cell lines and tissues.
View article: Supplementary Figure S1 from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer
Supplementary Figure S1 from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer Open
CDA expression levels in cancer cell lines and tissues.
View article: Supplementary Materials 1 and 2 from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer
Supplementary Materials 1 and 2 from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer Open
Cell lines (Supplementary Material 1), Primer sequences and Antibodies (Supplementary Material 2).
View article: Supplementary information from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer
Supplementary information from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer Open
Supplementary Figure Legends, Supplementary Table Legends, Supplementary Material Legends
View article: Supplementary Tables S2A and S2B from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer
Supplementary Tables S2A and S2B from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer Open
Single-nucleotide polymorphisms identified by direct sequencing of the CDA gene in breast cell lines (S2A) and NCI60 cell lines (S2B).
View article: Data from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer
Data from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer Open
Purpose: One of the main challenges in cancer therapy is the identification of molecular mechanisms mediating resistance or sensitivity to treatment. Cytidine deaminase (CDA) was reported to be downregulated in cells derived from patients …
View article: Supplementary Figure S2 from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer
Supplementary Figure S2 from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer Open
Experiments related to studies on the silencing of CDA gene expression.
View article: Supplementary Tables S2A and S2B from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer
Supplementary Tables S2A and S2B from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer Open
Single-nucleotide polymorphisms identified by direct sequencing of the CDA gene in breast cell lines (S2A) and NCI60 cell lines (S2B).
View article: Supplementary Table S3 from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer
Supplementary Table S3 from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer Open
Pearson correlation between the levels of CDA transcripts and the cytotoxicity of a panel of drugs.
View article: Data from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer
Data from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer Open
Purpose: One of the main challenges in cancer therapy is the identification of molecular mechanisms mediating resistance or sensitivity to treatment. Cytidine deaminase (CDA) was reported to be downregulated in cells derived from patients …
View article: Supplementary Figure S2 from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer
Supplementary Figure S2 from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer Open
Experiments related to studies on the silencing of CDA gene expression.
View article: Supplementary Table S1 from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer
Supplementary Table S1 from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer Open
Comparison of CDA mRNA expression data between cancerous and non-cancerous tissues.
View article: Supplementary Materials 1 and 2 from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer
Supplementary Materials 1 and 2 from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer Open
Cell lines (Supplementary Material 1), Primer sequences and Antibodies (Supplementary Material 2).
View article: Supplementary information from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer
Supplementary information from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer Open
Supplementary Figure Legends, Supplementary Table Legends, Supplementary Material Legends